article thumbnail

Can genetic data be a magic bullet for drug R&D?

pharmaphorum

As part of the US government’s Cancer Moonshot initiative, a Cancer Moonshot Biobank was launched that asked participants to donate biospecimens and associated health information to aid research. As well as the drug candidate discovered alongside GSK, 23andMe has also developed its own investigational antibody, 23ME-00610.

article thumbnail

Evotec, Chinook Teams Up for CKD Therapy; HitGen & UPPTHERA in Drug Delivery Research; Artiva’s $120 M Coup of NK Cell Therapy; Junshi & AZ with Toripalimab in China

Delveinsight

Chinook will have access to the NURTuRE cohort study along with other proprietary patient biobanks and Evotec’s multi-omics integration platform, and the company plans to potentially deliver targeted therapies in rare kidney diseases such as IgA nephropathy and glomerular diseases.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

THE RISING REALM: BIOPRESERVATION MEDIA INDUSTRY

Roots Analysis

The advancements and research in the field of cellular therapies, regenerative medicine, biobanking and drug discovery have led to the demand for biopreservation media in the pharmaceutical, biotechnology and healthcare sector. The figure below portrays the various sectors / segments where media can be employed.

In-Vivo 52
article thumbnail

Research Roundup: Blood Test for Severe COVID-19 and More

The Pharma Data

Doctors need better tools to evaluate the status of COVID-19 patients as early as possible because many of the treatments—such as monoclonal antibodies—are in short supply, and we know that some patients will get better without intensive treatments,” said co-senior author Andrew E. The research was published in the journal JCI Insight.